Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy

Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy

  • CN 1,684,972 A
  • Filed: 09/26/2003
  • Published: 10/19/2005
  • Est. Priority Date: 09/27/2002
  • Status: Active Application
First Claim
Patent Images

1. , a kind of conjugate, comprise one on it at least operationally in conjunction with the polymkeric substance of two synthetic peptide molecules, wherein each synthetic peptide molecule operationally is attached on this polymkeric substance by a reactive functionality, wherein each synthetic peptide comprises the aminoacid sequence of 7 one group of repeat regions that derive from virus of AIDS (HIV) gp41, wherein synthetic peptide comprise be not less than about 16 amino acid and no more than about 60 amino acid whose aminoacid sequences and wherein this conjugate have the persistence that comprises at the antiviral activity that can resist the independent HIV bacterial strain that synthesizes peptide.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×